Fenoget
(Fenofibrate)
Lipid-Adjusting Agent
Orally Administered Drug
Composition:
The initial dose of Fenoget for kidney patients should be 67 mg per day and this dose should be increased only after evaluating its effects.
Fenoget is not suitable for use for:
Safety of use of this drug in infants has not been established.
Fenoget should be used during pregnancy only when the benefits of the drug-use outweigh the risks.
(Fenofibrate)
Lipid-Adjusting Agent
Orally Administered Drug
Composition:
| | Fenoget | Capsules |
| | 67 mg | 200 mg |
| Amount of Fenofibrate | 67 mg | 200 mg |
The initial dose of Fenoget for kidney patients should be 67 mg per day and this dose should be increased only after evaluating its effects.
Fenoget is not suitable for use for:
- Patients allergic to any constituent of the drug
- Patients having severe kidney problems
- Patients having liver problems
- Breast-feeding mothers
Safety of use of this drug in infants has not been established.
Fenoget should be used during pregnancy only when the benefits of the drug-use outweigh the risks.
No comments:
Post a Comment